Skip to content
PubMed This is a summary of 52 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 52 referenced papers

Top Authors

Belinda S. Parker
The University of Melbourne
Natasha K. Brockwell
The University of Melbourne
Katie L. Owen
The University of Melbourne
Jean‐Laurent Casanova
Rockefeller University
Lingyong Jiang
Shanghai Stomatological Hospital
Alexandra F. Freeman
National Institute of Allergy and Infectious Diseases
Stuart G. Tangye
Garvan Institute of Medical Research
Joshua D. Milner
Columbia University
Siru Zhou
Shanghai Jiao Tong University

Top Institutions

Ranked by publications Top 10 institutions
05

Shanghai Jiao Tong University

Shanghai, China

40 papers
06
10

University of North Carolina at Chapel Hill

Chapel Hill, United States

34 papers

References

References (52)
  1. 1

    PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome.

    Frans G, Moens L, Schrijvers R, et al.

    Journal of clinical immunology 2015; (35(8)):739-44 doi:10.1007/s10875-015-0205-x.

    PMID: 26472314
  2. 2

    The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.

    Yanagimachi M, Ohya T, Yokosuka T, et al.

    Journal of clinical immunology 2016; (36(5)):511-6 doi:10.1007/s10875-016-0278-1.

    PMID: 27091139
  3. 3

    TH17 Cells in STAT3 Related Hyper-IgE Syndrome.

    Sharma S, Saikia B, Goel S, et al.

    Indian journal of pediatrics 2016; (83(10)):1104-8 doi:10.1007/s12098-016-2150-y.

    PMID: 27226025
  4. 4

    B-cell-specific STAT3 deficiency: Insight into the molecular basis of autosomal-dominant hyper-IgE syndrome.

    Kane A, Lau A, Brink R, et al.

    The Journal of allergy and clinical immunology 2016; (138(5)):1455-1458.e3 doi:10.1016/j.jaci.2016.05.018.

    PMID: 27423495
  5. 5

    Hyper-IgE Syndromes and the Lung.

    Freeman AF, Olivier KN

    Clinics in chest medicine 2016; (37(3)):557-67.

    PMID: 27514600
  6. 6

    [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].

    Alcántara-Montiel JC, Vega-Torres BI

    Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2016; (63(4)):385-396 doi:10.29262/ram.v63i4.217.

    PMID: 27795219
  7. 7

    Liver abscess in a boy with hyper IgE syndrome.

    Nandy S, Shah I

    Journal of family medicine and primary care 2016; (5(2)):491-492 doi:10.4103/2249-4863.192353.

    PMID: 27843873
  8. 8

    AD Hyper-IgE Syndrome Due to a Novel Loss-of-Function Mutation in STAT3: a Diagnostic Pursuit Won by Clinical Acuity.

    Moens L, Schaballie H, Bosch B, et al.

    Journal of clinical immunology 2017; (37(1)):12-17 doi:10.1007/s10875-016-0351-9.

    PMID: 27844301
  9. 9

    Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.

    Abd-Elmoniem KZ, Ramos N, Yazdani SK, et al.

    Atherosclerosis 2017; (258()):20-25 doi:10.1016/j.atherosclerosis.2017.01.022.

    PMID: 28167354
  10. 10

    Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

    Gernez Y, Freeman AF, Holland SM, et al.

    The journal of allergy and clinical immunology. In practice 2018; (6(3)):996-1001 doi:10.1016/j.jaip.2017.06.041.

    PMID: 28939137
  11. 11

    Pediatric hyperimmunoglobulin E syndrome: A case series of 4 children in China.

    Fan H, Huang L, Yang D, et al.

    Medicine 2018; (97(14)):e0215 doi:10.1097/MD.0000000000010215.

    PMID: 29620631
  12. 12

    [Hyper-IgE syndromes].

    He YY, Liu B, Xiao XP

    Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery 2017; (31(11)):892-896 doi:10.13201/j.issn.1001-1781.2017.11.019.

    PMID: 29775011
  13. 13

    A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

    Béziat V, Li J, Lin JX, et al.

    Science immunology 2018; (3(24)) doi:10.1126/sciimmunol.aat4956.

    PMID: 29907691
  14. 14

    Who regulates whom: ZNF341 is an additional player in the STAT3/TH17 song.

    August A

    Science immunology 2018; (3(24)) doi:10.1126/sciimmunol.aat9779.

    PMID: 29907692
  15. 15

    TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.

    Myles IA, Anderson ED, Earland NJ, et al.

    The Journal of clinical investigation 2018; (128(8)):3595-3604.

    PMID: 30035749
  16. 16

    Human hyper-IgE syndrome: singular or plural?

    Zhang Q, Boisson B, Béziat V, et al.

    Mammalian genome : official journal of the International Mammalian Genome Society 2018; (29(7-8)):603-617 doi:10.1007/s00335-018-9767-2.

    PMID: 30094507
  17. 17

    A Novel STAT3 Gene Mutation Related Hyper-IgE Syndrome Misdiagnosed as Hidradenitis Suppurativa.

    Shrestha P, Sabharwal G, Ghaffari G

    Case reports in immunology 2018; (2018()):4860902 doi:10.1155/2018/4860902.

    PMID: 30186644
  18. 18

    Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function.

    Shahin T, Aschenbrenner D, Cagdas D, et al.

    Haematologica 2019; (104(3)):609-621 doi:10.3324/haematol.2018.194233.

    PMID: 30309848
  19. 19

    An Update on Syndromes with a Hyper-IgE Phenotype.

    Bergerson JRE, Freeman AF

    Immunology and allergy clinics of North America 2019; (39(1)):49-61 doi:10.1016/j.iac.2018.08.007.

    PMID: 30466772
  20. 20

    Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.

    Gernez Y, Baker MG, Maglione PJ

    Transfusion 2018; (58 Suppl 3()):3056-3064 doi:10.1111/trf.15020.

    PMID: 30536429
  21. 21

    Lung disease in STAT3 hyper-IgE syndrome requires intense therapy.

    Kröner C, Neumann J, Ley-Zaporozhan J, et al.

    Allergy 2019; (74(9)):1691-1702 doi:10.1111/all.13753.

    PMID: 30793327
  22. 22

    The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.

    Tavassoli M, Abolhassani H, Yazdani R, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2019; (30(4)):469-478 doi:10.1111/pai.13043.

    PMID: 30801830
  23. 23

    Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression.

    Todaro F, Tamassia N, Pinelli M, et al.

    Haematologica 2019; (104(7)):e322-e325 doi:10.3324/haematol.2018.202374.

    PMID: 31073074
  24. 24

    JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression.

    Owen KL, Brockwell NK, Parker BS

    Cancers 2019; (11(12)) doi:10.3390/cancers11122002.

    PMID: 31842362
  25. 25

    Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential.

    Meixner I, Hagl B, Kröner CI, et al.

    Orphanet journal of rare diseases 2020; (15(1)):244 doi:10.1186/s13023-020-01516-3.

    PMID: 32912316
  26. 26

    Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE Syndrome.

    Ponsford MJ, Clark J, Mock J, et al.

    Frontiers in pediatrics 2020; (8()):575 doi:10.3389/fped.2020.00575.

    PMID: 33014947
  27. 27

    Oral ulcerations in a patient with autosomal dominant hyper-IgE syndrome (AD-HIES).

    Borst J, Ma L

    BMJ case reports 2020; (13(11)) doi:10.1136/bcr-2020-236705.

    PMID: 33139362
  28. 28

    A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.

    Kasap N, Celik V, Isik S, et al.

    Clinical immunology (Orlando, Fla.) 2021; (223()):108645 doi:10.1016/j.clim.2020.108645.

    PMID: 33301882
  29. 29

    Benralizumab for Prednisone-Dependent Eosinophilic Asthma Associated With Novel STAT3 Loss of Function Mutation.

    Adatia A, Allen CJ, Wald J, et al.

    Chest 2021; (159(4)):e181-e184 doi:10.1016/j.chest.2020.11.042.

    PMID: 34022014
  30. 30

    Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.

    Asano T, Khourieh J, Zhang P, et al.

    The Journal of experimental medicine 2021; (218(8)) doi:10.1084/jem.20202592.

    PMID: 34137790
  31. 31

    Hyper-IgE syndrome, 2021 update.

    Minegishi Y

    Allergology international : official journal of the Japanese Society of Allergology 2021; (70(4)):407-414 doi:10.1016/j.alit.2021.07.007.

    PMID: 34419355
  32. 32

    STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis.

    Zhou S, Dai Q, Huang X, et al.

    Nature communications 2021; (12(1)):6891 doi:10.1038/s41467-021-27273-w.

    PMID: 34824272
  33. 33

    JMJD3 Promotes Porphyromonas gingivalis Lipopolysaccharide-Induced Th17-Cell Differentiation by Modulating the STAT3-RORc Signaling Pathway.

    Huang D, Zhang C, Wang P, et al.

    DNA and cell biology 2022; (41(8)):778-787 doi:10.1089/dna.2022.0149.

    PMID: 35867069
  34. 34

    Immunosuppression in Patients With Primary Immunodeficiency-Walking the Line.

    Mustafa SS, Rider NL, Jolles S

    The journal of allergy and clinical immunology. In practice 2022; (10(12)):3088-3096 doi:10.1016/j.jaip.2022.08.025.

    PMID: 36049628
  35. 35

    Osteoblastic STAT3 Is Crucial for Orthodontic Force Driving Alveolar Bone Remodeling and Tooth Movement.

    Gong X, Sun S, Yang Y, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2023; (38(1)):214-227 doi:10.1002/jbmr.4744.

    PMID: 36370067
  36. 36

    The signal transducer and activator of transcription 3 at the center of the causative gene network of the hyper-IgE syndrome.

    Minegishi Y

    Current opinion in immunology 2023; (80()):102264 doi:10.1016/j.coi.2022.102264.

    PMID: 36435159
  37. 37

    STAT3 mutation-associated airway epithelial defects in Job syndrome.

    Zhang Y, Lin T, Leung HM, et al.

    The Journal of allergy and clinical immunology 2023; (152(2)):538-550 doi:10.1016/j.jaci.2022.12.821.

    PMID: 36638921
  38. 38

    Dupilumab in the treatment of genodermatosis: A systematic review.

    Wu PC, Dai YX, Li CL, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(1)):7-17 doi:10.1111/ddg.14924.

    PMID: 36657040
  39. 39

    Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job's syndrome.

    Carrabba M, Dellepiane RM, Cortesi M, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2023; (19(1)):32 doi:10.1186/s13223-023-00776-5.

    PMID: 37081481
  40. 40

    Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome.

    Tar I, Szegedi M, Krasuska-Sławińska E, et al.

    Central-European journal of immunology 2023; (48(3)):228-236 doi:10.5114/ceji.2023.130874.

    PMID: 37901871
  41. 41

    [Recurrence of a Giant Emphysematous Bulla After Bullectomy:Report of a Case].

    Inoue Y, Yoshida D, Yotsumoto T, et al.

    Kyobu geka. The Japanese journal of thoracic surgery 2023; (76(12)):1065-1068.

    PMID: 38057987
  42. 42

    Resolving persistent air leaks associated with autosomal dominant hyper-IgE syndrome using one-way endobronchial valves: report of cases.

    Kucera J, Buhaya M, Sartain NN, et al.

    AME case reports 2024; (8()):43 doi:10.21037/acr-23-35.

    PMID: 38711888
  43. 43

    Identifying potentially undiagnosed individuals with hyper-IgE syndrome using a scoring system.

    Finkelshtain S, Cohen-Engler A, Rosman Y, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (133(6)):696-702.e2 doi:10.1016/j.anai.2024.07.028.

    PMID: 39103119
  44. 44

    Challenges in diagnosing and managing hyper-IgE syndrome in a resource-limited setting: a case report.

    Adhikari P, Regmi R, Yadav PS, Kafle S

    Annals of medicine and surgery (2012) 2024; (86(9)):5582-5585 doi:10.1097/MS9.0000000000002407.

    PMID: 39238996
  45. 45

    Phenotypes of 126 Moroccan HIES patients according to NIH Score.

    Fadil I, Benhsaien I, El Bakkouri J, et al.

    La Tunisie medicale 2024; (102(10)):696-701 doi:10.62438/tunismed.v102i10.5148.

    PMID: 39441153
  46. 46

    Whole-exome sequencing assists in the diagnosis of hyperimmunoglobulin E syndrome: Insights into dual genetic abnormalities.

    Li SY, Cao W, Ge Y, et al.

    Heliyon 2025; (11(4)):e42408 doi:10.1016/j.heliyon.2025.e42408.

    PMID: 40028518
  47. 47

    The genetics of hyper IgE syndromes.

    AlYafie R, Velayutham D, van Panhuys N, Jithesh PV

    Frontiers in immunology 2025; (16()):1516068 doi:10.3389/fimmu.2025.1516068.

    PMID: 40040707
  48. 48

    STAT3-Dependent Regulation of CFTR and Ciliogenesis Is Essential for Mucociliary Clearance and Innate Airway Defense in Hyper-IgE Syndrome.

    Sun L, Walls SA, Dang H, et al.

    American journal of respiratory and critical care medicine 2025; (211(10)):1951-1969 doi:10.1164/rccm.202407-1415OC.

    PMID: 40315437
  49. 49

    Case Report: Biliary hemorrhage by intrahepatic pseudoaneurysm and asymptomatic right coronary artery pseudoaneurysm in a patient with STAT3 hyper IgE syndrome.

    Fujita D, Ueki M, Yamanaka H, et al.

    Frontiers in immunology 2025; (16()):1601776 doi:10.3389/fimmu.2025.1601776.

    PMID: 40491905
  50. 50

    Adenoidal hypertrophy and pulmonary bullae in a child: a case report.

    Ding L, Jiang H

    Journal of medical case reports 2025; (19(1)):276 doi:10.1186/s13256-025-05339-3.

    PMID: 40514724
  51. 51

    Intraoperative Pneumatocele Formation during Liver Transplantation for Polycystic Liver Disease: Successful Non-Operative Management.

    Takada S, Nakanuma S, Kobori R, et al.

    Surgical case reports 2025; (11(1)) doi:10.70352/scrj.cr.25-0341.

    PMID: 40923012
  52. 52

    Understanding and Managing Hyper IgE Syndromes.

    Meric Z, Aydin M, Demir Gumus D, et al.

    ImmunoTargets and therapy 2025; (14()):1233-1245 doi:10.2147/ITT.S532287.

    PMID: 41216363